Invivyd, Inc. - Common Stock, $0.0001 par value per share (IVVD)
CUSIP: 00534A102
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock, $0.0001 par value per share
- Shares outstanding
- 291,486,949
- Total 13F shares
- 75,942,683
- Share change
- +3,533,613
- Total reported value
- $83,535,902
- Put/Call ratio
- 0.08%
- Price per share
- $1.10
- Number of holders
- 78
- Value change
- -$14,530,712
- Number of buys
- 48
- Number of sells
- 46
Quarterly Holders Quick Answers
What is CUSIP 00534A102?
CUSIP 00534A102 identifies IVVD - Invivyd, Inc. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 00534A102:
Top shareholders of IVVD - Invivyd, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Adimab, LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
21,687,906
|
$85,667,229 | — | 19 Jan 2024 | |
| MAVERICK CAPITAL LTD |
13F
|
Company |
4%
|
11,765,787
|
$52,240,094 | — | 31 Mar 2024 | |
| Deep Track Capital, LP |
13F
|
Company |
3.8%
|
10,953,937
|
$48,635,480 | — | 31 Mar 2024 | |
| MITHRIL II LP |
3/4/5
|
Other*, 10%+ Owner |
—
class O/S missing
|
11,241,580
|
$44,404,241 | — | 28 Mar 2022 | |
| M28 Capital Management LP |
13F
|
Company |
3.2%
|
9,248,250
|
$41,062,230 | — | 31 Mar 2024 | |
| FMR LLC |
13F
|
Company |
2.9%
|
8,406,664
|
$37,325,585 | — | 31 Mar 2024 | |
| Alphabet Inc. |
13F
|
Company |
1.6%
|
4,527,122
|
$20,100,421 | — | 31 Mar 2024 | |
| Slate Path Capital LP |
13F
|
Company |
1.3%
|
3,735,000
|
$16,583,400 | — | 31 Mar 2024 | |
| 683 Capital Management, LLC |
13F
|
Company |
1.2%
|
3,475,000
|
$15,429,000 | — | 31 Mar 2024 | |
| Redmile Group, LLC |
3/4/5
13F
|
10%+ Owner · Company |
0.49%
from 13F
|
3,390,960
|
$13,394,292 | — | 10 Aug 2021 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.92%
|
2,690,300
|
$11,944,932 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.9%
|
2,611,202
|
$11,593,737 | — | 31 Mar 2024 | |
| Bain Capital Life Sciences Investors, LLC |
13F
|
Company |
0.62%
|
1,799,595
|
$7,990,202 | — | 31 Mar 2024 | |
| Rene Russo |
3/4/5
|
Director |
—
mixed-class rows
|
2,020,888
mixed-class rows
|
$7,841,915 | — | 05 Aug 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.52%
|
1,523,342
|
$6,763,638 | — | 31 Mar 2024 | |
| GILDER GAGNON HOWE & CO LLC |
13F
|
Company |
0.43%
|
1,249,111
|
$5,546,053 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.3%
|
876,569
|
$3,891,967 | — | 31 Mar 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.26%
|
754,907
|
$3,351,788 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.21%
|
611,459
|
$2,715,507 | — | 31 Mar 2024 | |
| Cox Christopher T. |
3/4/5
|
Other* |
—
class O/S missing
|
679,822
|
$2,685,297 | — | 28 Mar 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.21%
|
602,907
|
$2,676,907 | — | 31 Mar 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.2%
|
585,385
|
$2,599,109 | — | 31 Mar 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.19%
|
567,667
|
$2,520,442 | — | 31 Mar 2024 | |
| Polaris Venture Partners V, L.P. |
3/4/5
|
Other* |
—
class O/S missing
|
497,660
|
$1,965,757 | — | 28 Mar 2022 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.15%
|
435,338
|
$1,932,901 | — | 31 Mar 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.11%
|
326,065
|
$1,447,729 | — | 31 Mar 2024 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.11%
|
325,300
|
$1,444,332 | — | 31 Mar 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.11%
|
312,429
|
$1,387,185 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.11%
|
311,254
|
$1,381,968 | — | 31 Mar 2024 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.1%
|
284,461
|
$1,263,007 | — | 31 Mar 2024 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.07%
|
204,405
|
$905,000 | — | 31 Mar 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.07%
|
202,831
|
$900,570 | — | 31 Mar 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.07%
|
201,732
|
$895,690 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.07%
|
189,757
|
$842,521 | — | 31 Mar 2024 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.05%
|
146,619
|
$650,000 | — | 31 Mar 2024 | |
| Man Group plc |
13F
|
Company |
0.05%
|
142,021
|
$630,573 | — | 31 Mar 2024 | |
| RBF Capital, LLC |
13F
|
Company |
0.05%
|
140,000
|
$621,600 | — | 31 Mar 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.05%
|
135,761
|
$602,779 | — | 31 Mar 2024 | |
| Marathon Trading Investment Management LLC |
13F
|
Company |
0.04%
|
111,900
|
$496,836 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.04%
|
110,695
|
$491,485 | — | 31 Mar 2024 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.03%
|
81,113
|
$360,142 | — | 31 Mar 2024 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.03%
|
80,953
|
$359,431 | — | 31 Mar 2024 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.03%
|
80,230
|
$356,221 | — | 31 Mar 2024 | |
| a16z Perennial Management, L.P. |
13F
|
Company |
0.03%
|
79,869
|
$354,618 | — | 31 Mar 2024 | |
| Acuitas Investments, LLC |
13F
|
Company |
0.03%
|
77,195
|
$342,746 | — | 31 Mar 2024 | |
| Point72 Asia (Singapore) Pte. Ltd. |
13F
|
Company |
0.03%
|
75,101
|
$333,448 | — | 31 Mar 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.02%
|
65,557
|
$291,073 | — | 31 Mar 2024 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.02%
|
63,453
|
$282,000 | — | 31 Mar 2024 | |
| CHASE INVESTMENT COUNSEL CORP |
13F
|
Company |
0.02%
|
61,097
|
$271,000 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.02%
|
59,529
|
$264,309 | — | 31 Mar 2024 |
Institutional Holders of Invivyd, Inc. - Common Stock, $0.0001 par value per share (IVVD) as of Q2 2024
As of 30 Jun 2024,
Invivyd, Inc. - Common Stock, $0.0001 par value per share (IVVD) was held by
78 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
75,942,683 shares.
The largest 10 holders included
MAVERICK CAPITAL LTD, Deep Track Capital, LP, M28 Capital Management LP, FMR LLC, BlackRock Inc., VANGUARD GROUP INC, Slate Path Capital LP, 683 Capital Management, LLC, Redmile Group, LLC, and ORBIMED ADVISORS LLC.
This page lists
78
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
85
Q2 2024 holders
78
Holder diff
-7
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.